Reko Diq (Lab & Field Staff) Medical Screening at Chughtai Lab

Reko Diq (Lab & Field Staff) Medical Screening at Chughtai Lab

The Reko Diq (Lab & Field Staff) medical screening at Chughtai Lab is a highly specialized, comprehensive occupational health assessment designed specifically for personnel deployed to the Reko Diq mining project in Balochistan, Pakistan. Working in remote, high-altitude, and geologically complex environments presents unique physiological challenges. Field staff are routinely exposed to extreme weather conditions, physical exertion, airborne dust, silica, and heavy metals, while laboratory staff handle hazardous chemical reagents, solvents, and geological samples. To ensure the safety, health, and operational readiness of these workers, Chughtai Lab has developed a targeted diagnostic panel that evaluates key physiological systems, including hematological, hepatic, renal, metabolic, cardiovascular, and respiratory functions.

This occupational health panel utilizes state-of-the-art laboratory technology and diagnostic imaging to establish a robust baseline of health and monitor ongoing physiological changes. By identifying pre-existing conditions, early signs of organ dysfunction, or occupational exposures, the screening helps prevent medical emergencies in remote locations where advanced healthcare facilities may be hours or days away. The evaluation includes a detailed battery of tests such as a Complete Blood Count (CBC) to detect anemia or infection, Liver Function Tests (LFTs) and Renal Function Tests (RFTs) to monitor metabolic and excretory organs, Blood Glucose testing to assess metabolic health, and screening for infectious diseases like Hepatitis B and C. Additionally, cardiopulmonary assessments, including Electrocardiograms (ECG) and chest radiography, are integrated to ensure that field staff possess the physical capacity to withstand the rigorous demands of mining operations. Through this rigorous screening, Chughtai Lab supports both individual worker well-being and corporate compliance with international occupational health and safety standards.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to guarantee the accuracy and reliability of the laboratory and diagnostic results. Patients undergoing the Reko Diq (Lab & Field Staff) medical screening must adhere to the following guidelines:

• Fasting Requirements: Patients must fast for 10 to 12 hours prior to the blood draw. Only plain water is permitted during this period. Avoid tea, coffee, juices, sodas, and food, as these can significantly alter blood glucose and lipid levels.
• Medication Management: Continue taking essential daily medications as prescribed by your physician, unless specifically instructed otherwise. Inform the Chughtai Lab staff of all medications, vitamins, and supplements you are currently taking.
• Avoid Physical Exertion: Refrain from strenuous exercise, heavy lifting, or intense physical activity for 24 hours before the test, as this can elevate muscle enzymes and affect renal function markers like creatinine.
• Hydration: Drink adequate amounts of plain water during the fasting period. Good hydration ensures stable blood pressure, facilitates easier venous access for blood collection, and provides an optimal urine sample.
• Avoid Alcohol and Tobacco: Do not consume alcohol or use tobacco products for at least 24 hours prior to the screening, as these substances can interfere with liver enzyme measurements and cardiovascular readings.
• Appropriate Clothing: Wear loose, comfortable clothing that allows easy access to your arms for blood collection and can be easily adjusted for an ECG or chest X-ray if those components are included in your specific corporate package.

During the Procedure

The Reko Diq (Lab & Field Staff) medical screening is a multi-step process conducted in a professional, hygienic, and highly controlled clinical environment at Chughtai Lab:

• Registration and Documentation: Upon arrival, the patient’s identity is verified using official identification (such as a CNIC or employee card). A brief occupational history and medical questionnaire are completed to document any current symptoms or known exposures.
• Venipuncture (Blood Sample Collection): A certified phlebotomist will locate a suitable vein, typically in the inner elbow. The area is thoroughly sanitized with an antiseptic wipe. A sterile, single-use needle is inserted to collect the required volume of blood into specific vacuum tubes. A small bandage is applied to the puncture site, and pressure is maintained for a few minutes to prevent bruising.
• Urine Sample Collection: The patient is provided with a sterile, labeled container and instructed on how to collect a clean-catch midstream urine sample. This technique minimizes contamination from external skin flora.
• Cardiovascular Assessment (ECG): If an ECG is part of the screening, the patient will lie flat on an examination table. Small adhesive electrodes are placed on specific locations on the chest, arms, and legs. The ECG machine records the electrical activity of the heart over a few minutes. This process is entirely painless and non-invasive.
• Imaging and Pulmonary Tests: If chest radiography or spirometry is required, the patient will be guided to the imaging department. Standard safety protocols, including lead shielding where appropriate, are strictly followed to minimize radiation exposure during X-rays.
• Duration and Safety: The entire collection and assessment process typically takes between 45 to 90 minutes, depending on the specific components of the corporate screening package. All procedures are conducted under strict biosafety protocols to ensure patient safety and comfort.

When is a Reko Diq (Lab & Field Staff) Medical Screening Performed?

Pre-Employment Occupational Fitness Assessment

Before any employee is deployed to the Reko Diq mining site, a comprehensive pre-employment medical screening is mandatory. This baseline evaluation ensures that prospective lab and field staff do not have underlying health conditions that could be exacerbated by the harsh environmental conditions of Balochistan. It verifies that workers have the physical stamina, respiratory health, and metabolic stability required to perform their duties safely, reducing the risk of acute medical crises in a remote field setting.

Routine Annual Health Surveillance

For active field and laboratory personnel, this screening is performed annually or semi-annually as part of an ongoing occupational health surveillance program. Continuous exposure to silica dust, heavy metals, diesel exhaust, and chemical reagents can cause gradual, asymptomatic physiological changes. Regular screening allows occupational health physicians to detect early signs of respiratory decline, renal impairment, or hepatotoxicity, enabling timely intervention, job rotation, or environmental modifications before permanent damage occurs.

Evaluation of Respiratory and Cardiorespiratory Capacity

Mining environments are characterized by high dust levels and physically demanding labor, which place a heavy burden on the respiratory and cardiovascular systems. Physicians request this screening when workers report symptoms such as chronic cough, shortness of breath, chest tightness, or unexplained fatigue. The integration of pulmonary assessments and electrocardiograms helps diagnose conditions like occupational asthma, early pneumoconiosis, or cardiac arrhythmias that could compromise worker safety during strenuous field tasks.

Monitoring for Chemical and Heavy Metal Exposure

Laboratory staff at the Reko Diq site handle various chemical reagents, acids, and solvents used in mineral analysis, while field staff may be exposed to naturally occurring heavy metals in soil and rock dust. This screening is performed to monitor organ function, particularly liver and kidney health, which are the primary pathways for metabolizing and excreting toxins. Elevated liver enzymes or serum creatinine levels serve as early indicators of chemical-induced toxicity, prompting immediate review of laboratory safety protocols and personal protective equipment (PPE) compliance.

Post-Incident or Return-to-Duty Medical Clearance

Following an occupational injury, severe illness, or prolonged medical leave, workers must undergo this comprehensive screening before returning to active duty at the Reko Diq site. This assessment ensures that the employee has fully recovered, possesses the necessary physical capacity, and does not have residual organ dysfunction or weakness that would endanger themselves or their colleagues in the high-risk mining environment.

What Does a Reko Diq (Lab & Field Staff) Medical Screening Detect?

The Reko Diq (Lab & Field Staff) medical screening at Chughtai Lab is designed to detect a wide range of subclinical conditions, acute illnesses, and chronic occupational health issues. By analyzing hematological, biochemical, and physiological markers, this panel can identify:

• Anemia: Low hemoglobin levels indicating reduced oxygen-carrying capacity, which can lead to severe fatigue and decreased physical tolerance in demanding field environments.
• Infections and Inflammatory States: Elevated white blood cell counts (leukocytosis) suggesting active bacterial infections or systemic inflammation.
• Thrombocytopenia or Thrombocytosis: Abnormal platelet counts that could affect blood clotting and increase the risk of bleeding or thrombotic events.
• Hepatocellular Injury: Elevated levels of Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), indicating liver cell damage potentially caused by chemical exposure, alcohol, or viral hepatitis.
• Biliary Obstruction: Increased Alkaline Phosphatase (ALP) and Bilirubin levels, pointing to potential gallbladder or bile duct issues.
• Renal Impairment: Elevated Serum Creatinine and Blood Urea Nitrogen (BUN) levels, indicating compromised kidney function or severe dehydration.
• Impaired Glucose Tolerance and Diabetes: Elevated fasting blood glucose levels, identifying undiagnosed diabetes mellitus or prediabetes, which require careful metabolic management.
• Urinary Tract Infections (UTIs): Presence of leucocytes, nitrites, and bacteria in urine, indicating an active infection of the urinary tract.
• Renal Pathology: Microscopic hematuria (blood in urine) or proteinuria (protein in urine), which can be early signs of glomerular disease, kidney stones, or occupational nephrotoxicity.
• Electrolyte Imbalances: Abnormal levels of sodium, potassium, or chloride, which can cause muscle cramps, cardiac arrhythmias, and heat-related illnesses in desert mining environments.
• Hepatitis B Infection: Presence of Hepatitis B Surface Antigen (HBsAg), indicating an active or chronic infection that poses a transmission risk and requires medical management.
• Hepatitis C Infection: Presence of Anti-HCV antibodies, identifying chronic hepatitis C infection which can lead to progressive liver cirrhosis if left untreated.
• Cardiac Arrhythmias: Abnormal electrical pathways or irregular heart rhythms detected via ECG, which could pose sudden cardiac risks during physical exertion.
• Myocardial Ischemia: ECG changes suggestive of compromised blood flow to the heart muscle, indicating coronary artery disease.
• Cardiomegaly: Enlargement of the heart, often associated with chronic hypertension, detectable via chest radiography.
• Occupational Pneumoconiosis: Early signs of lung dust disease, such as silicosis, visible as nodular opacities on a chest X-ray.
• Pulmonary Congestion or Infection: Evidence of bronchitis, pneumonia, or pleural effusion on chest imaging.
• Hyperuricemia: Elevated uric acid levels, which can lead to gouty arthritis or uric acid kidney stones.
• Dyslipidemia: Abnormal cholesterol and triglyceride profiles, indicating elevated cardiovascular risk.
• Chronic Obstructive Pulmonary Disease (COPD): Reduced lung volumes and airflow limitations, particularly in workers with a history of smoking or heavy dust exposure.
• Dehydration: Elevated urine specific gravity and concentrated blood markers, highlighting inadequate fluid intake in hot arid climates.
• Heavy Metal Toxicity: Indirect physiological signs of heavy metal exposure, such as basophilic stippling of red blood cells in lead poisoning.
• Systemic Hypertension: Elevated blood pressure readings during physical assessments, requiring medical control to prevent cardiovascular events.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, highly accurate, and easily accessible diagnostic reports. For the Reko Diq (Lab & Field Staff) medical screening, most routine pathology results (such as CBC, LFTs, RFTs, and urinalysis) are processed and verified within 24 to 48 hours of sample collection. Specialized tests, occupational health clearance reports, or imaging interpretations by consultant radiologists may take slightly longer to ensure comprehensive review and quality assurance.

Patients and corporate administrators can access reports seamlessly through multiple digital channels. Once the results are verified, an automated SMS notification containing a secure download link is sent to the patient’s registered mobile number. Reports can be viewed, downloaded, and printed directly from the official Chughtai Lab website by entering the patient’s case number and access code. Additionally, the Chughtai Lab Mobile App, available for both iOS and Android platforms, provides a secure portal for patients to view their entire diagnostic history, track health trends over time, and share reports directly with occupational health physicians or corporate medical officers. Physical copies of the reports can also be collected from any Chughtai Lab collection center nationwide.

Reko Diq (Lab & Field Staff) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hemoglobin (Hb)	13.5 – 17.5 g/dL (Males) 12.0 – 15.5 g/dL (Females)	Anemia (low Hb due to nutritional deficiency or chronic disease); Polycythemia (high Hb due to chronic hypoxia or dehydration).
White Blood Cell (WBC) Count	4,000 – 11,000 /µL	Leukocytosis (infection, inflammation, or physiological stress); Leukopenia (viral infections, bone marrow suppression).
Alanine Aminotransferase (ALT)	7 – 56 U/L	Elevated ALT (hepatocellular damage, toxic chemical exposure, viral hepatitis, or fatty liver disease).
Serum Creatinine	0.6 – 1.2 mg/dL (Males) 0.5 – 1.1 mg/dL (Females)	Elevated Creatinine (renal impairment, acute kidney injury, severe dehydration, or nephrotoxicity).
Fasting Blood Glucose	70 – 99 mg/dL	Impaired Fasting Glucose (100-125 mg/dL); Diabetes Mellitus (equal to or greater than 126 mg/dL).
Urine Protein	Negative / Trace	Proteinuria (early sign of renal disease, diabetic nephropathy, or heavy metal-induced kidney damage).
Hepatitis B Surface Antigen (HBsAg)	Non-Reactive	Reactive (indicates active acute or chronic Hepatitis B infection).
Electrocardiogram (ECG)	Normal Sinus Rhythm	Sinus tachycardia, bradycardia, atrial fibrillation, ventricular premature beats, or ST-T wave changes indicating ischemia.
Chest Radiography (X-Ray)	Clear lung fields; normal cardiothoracic ratio	Nodular opacities (pneumoconiosis/silicosis), pulmonary infiltrates (pneumonia), pleural thickening, or cardiomegaly.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Reko Diq (Lab & Field Staff) Medical Screening?

• ISO 15189 Certified Laboratories: Chughtai Lab maintains international standards of quality and competence, ensuring that all occupational health assessments are highly accurate and globally recognized.
• Nationwide Diagnostic Network: With hundreds of collection centers across Pakistan, Chughtai Lab offers unparalleled convenience for pre-deployment screening, allowing staff to be tested in their home cities before traveling to remote sites.
• Advanced Pathology Automation: Utilizing state-of-the-art, fully automated analyzers minimizes human error and guarantees rapid turnaround times for high-volume corporate screenings.
• Dedicated Corporate Health Services: Chughtai Lab provides tailored health packages, streamlined billing, and dedicated corporate coordinators to manage large-scale workforce screenings efficiently.
• Expert Medical Specialists: All laboratory reports are supervised and signed off by qualified consultant pathologists, while imaging studies are interpreted by experienced consultant radiologists.
• Comprehensive Digital Health Ecosystem: Patients and employers enjoy seamless access to reports via the Chughtai Lab Mobile App, secure online portals, and automated SMS notifications.
• Strict Biosafety and Quality Control: The lab adheres to rigorous internal and external quality assurance programs, ensuring safe sample handling and highly reliable diagnostic outcomes.
• Holistic Occupational Health Support: Beyond basic blood tests, Chughtai Lab offers integrated diagnostic services, including ECGs, digital X-rays, and specialist consultations, providing a complete health clearance solution.